Exploration of endoscopic findings and risk factors of early gastric cancer after eradication of Helicobacter pylori

Author(s):  
Xiaohan Yan ◽  
Xiao Hu ◽  
Bensong Duan ◽  
Xuesong Zhang ◽  
Jie Pan ◽  
...  
2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Liang Wang ◽  
Jinfeng Wang ◽  
Sha Li ◽  
Fei Bai ◽  
Hailong Xie ◽  
...  

Abstract Objective To investigate the effect of Helicobacter pylori (H. pylori) eradication on the prognosis of postoperative early gastric cancer (EGC). Methods This is a retrospective study based on data from 6 hospitals. We identified 429 patients with EGC who underwent curative gastrectomy from January 2010 to December 2016. All of the patients were tested for H. pylori. Patients were divided into two groups, the successful H. pylori eradication group (group A, 268 patients) and the non-H. pylori eradication group (group B, 161 patients), for calculating the disease-free survival (DFS) and overall survival (OS) of each group. Result Positive node metastasis (hazard ratio (HR), 3.13; 95% confidence interval (CI), 1.84–5.32; P < 0.001), undifferentiated type (HR, 2.54; 95% CI, 1.51–4.28; P < 0.001), and non-H. pylori eradication (HR, 1.73; 95% CI, 1.08–2.77; P = 0.023) were statistically significantly independent risk factors of recurrence. Patient’s age ≥60 years old (HR, 3.32; 95% CI, 2.00–5.53; P < 0.001), positive node metastasis (HR, 3.71; 95% CI, 2.25–6.12; P < 0.001), undifferentiated type (HR, 3.06; 95% CI, 1.79–5.23; P < 0.001), and non-H. pylori eradication (HR, 1.83; 95% CI, 1.11–3.02; P = 0.018) were statistically significantly independent risk factors of overall survival. Conclusion H. pylori eradication treatment could prevent the recurrence of postoperative EGC to prolong the overall survival of patients with EGC.


Digestion ◽  
2021 ◽  
pp. 1-8
Author(s):  
Satoki Shichijo ◽  
Noriya Uedo ◽  
Tomoki Michida

<b><i>Background:</i></b> Based on evidence that <i>Helicobacter pylori</i> eradication reduces the development of gastric cancer and other diseases such as peptic ulcer, eradication therapy has prevailed. However, gastric cancer can develop even after successful eradication. <b><i>Summary:</i></b> In this review article, we searched for studies that identified the characteristics of primary and metachronous gastric cancers after <i>H. pylori</i> eradication, the risk factors for the development of these cancers after successful <i>H. pylori</i> eradication, and whether image-enhanced endoscopy is useful for diagnosing gastric cancer after eradication. A gastritis-like appearance is seen as a characteristic endoscopic finding, which corresponds to an epithelium with low-grade atypia – also known as nonneoplastic epithelium – covering the surface of the cancerous glands. This finding may make endoscopic detection of early gastric cancer difficult after <i>H. pylori</i> eradication. Similar risk factors, such as the male sex, endoscopic atrophy, histologic intestinal metaplasia, and late eradication, have been reported as predictors for the development of both primary and metachronous gastric cancers. Image-enhanced endoscopy, such as linked color imaging, may be useful for the detection and risk stratification of gastric cancer after eradication. <b><i>Key Messages:</i></b> Based on these findings, we believe that effective surveillance of high-risk patients leads to early detection of gastric cancer in the era of <i>H. pylori</i> eradication.


2001 ◽  
Vol 120 (5) ◽  
pp. A658-A658
Author(s):  
E UMEGAKI ◽  
M TANAKA ◽  
N TAKEUCHI ◽  
K NISHIMURA ◽  
M NANRI ◽  
...  

2007 ◽  
Vol 69 (1) ◽  
pp. 8-10
Author(s):  
Ritsuko KANO ◽  
Yusuke YOSHIZAWA ◽  
Seiji KAWANA ◽  
Taku TSUKUI

Sign in / Sign up

Export Citation Format

Share Document